Biogen (NASDAQ:BIIB) Coverage Initiated at Sanford C. Bernstein
Sanford C. Bernstein began coverage on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage issued a market perform rating and a $160.00 target price on the biotechnology company’s stock. A number of other analysts also recently issued reports on the stock. BMO Capital […]
Sanford C. Bernstein began coverage on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage issued a market perform rating and a $160.00 target price on the biotechnology company’s stock. A number of other analysts also recently issued reports on the stock. BMO Capital […]
